SECONDARY HYPERPARATHYROIDISM

Clinical trials for SECONDARY HYPERPARATHYROIDISM explained in plain language.

Never miss a new study

Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear

Sign up with your email to follow new studies for SECONDARY HYPERPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Completed 3

New drug tested in kids to control kidney disease complications

Disease control Not yet recruiting

This study is testing an extended-release capsule called CTAP101 in children under 18 who have chronic kidney disease, a related hormone imbalance, and low vitamin D. The main goals are to see how the drug moves through the body, how it works, and if it is safe and tolerable. Abo…

Matched conditions: SECONDARY HYPERPARATHYROIDISM

Phase: PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

SECONDARY HYPERPARATHYROIDISM

Get alerted when new SECONDARY HYPERPARATHYROIDISM trials appear

New drug tested in kids to control kidney disease complications